Associations of sociodemographic factors and lifestyle behaviors with the risk of cardiometabolic disease: a population-based study from the European health interview survey in Hungary

BMC Public Health. 2026 Mar 2. doi: 10.1186/s12889-025-25689-3. Online ahead of print.ABSTRACTBACKGROUND: Cardiometabolic diseases (CMDs), including cardiovascular diseases (CVD), type 2 diabetes mellitus (T2DM), and metabolic syndrome, are major global health concerns. In Hungary, CVD mortality rem

C Chau Minh Nguyen

Health inequalities across England and their impact on cardiovascular diseases

Heart. 2026 Mar 1:heartjnl-2025-327508. doi: 10.1136/heartjnl-2025-327508. Online ahead of print.ABSTRACTCardiovascular disease (CVD) remains one of the leading causes of mortality in England, with its burden disproportionately concentrated in the North. Studies in the last few decades have highligh

V Vaishnavi Ratnasabesar

Long-term systemic effects of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD/MAFLD) in children: a systematic review of persistence and progression into adulthood

Ann Hepatol. 2026 Feb 27:102197. doi: 10.1016/j.aohep.2026.102197. Online ahead of print.ABSTRACTMetabolic dysfunction associated steatotic liver disease (MASLD), previously referred to as nonalcoholic fatty liver disease (NAFLD) and metabolic associated fatty liver disease (MAFLD), is increasingly

B Beatriz Rey-Garcia